AU2001292303A1 - Xanthone compound - Google Patents

Xanthone compound

Info

Publication number
AU2001292303A1
AU2001292303A1 AU2001292303A AU9230301A AU2001292303A1 AU 2001292303 A1 AU2001292303 A1 AU 2001292303A1 AU 2001292303 A AU2001292303 A AU 2001292303A AU 9230301 A AU9230301 A AU 9230301A AU 2001292303 A1 AU2001292303 A1 AU 2001292303A1
Authority
AU
Australia
Prior art keywords
xanthone compound
xanthone
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001292303A
Inventor
Tsutomu Ando
Zeng Xiang Chen
Yi Wen Chu
Akira Kawashima
Yuichi Terui
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sichuan Industrial Institute of Antibiotics
Taisho Pharmaceutical Co Ltd
Original Assignee
Sichuan Industrial Institute of Antibiotics
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sichuan Industrial Institute of Antibiotics, Taisho Pharmaceutical Co Ltd filed Critical Sichuan Industrial Institute of Antibiotics
Publication of AU2001292303A1 publication Critical patent/AU2001292303A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/16—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001292303A 2000-09-29 2001-09-28 Xanthone compound Abandoned AU2001292303A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-298572 2000-09-29
JP2000298572 2000-09-29
PCT/JP2001/008566 WO2002027010A1 (en) 2000-09-29 2001-09-28 Xanthone compound

Publications (1)

Publication Number Publication Date
AU2001292303A1 true AU2001292303A1 (en) 2002-04-08

Family

ID=18780513

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001292303A Abandoned AU2001292303A1 (en) 2000-09-29 2001-09-28 Xanthone compound

Country Status (3)

Country Link
JP (1) JPWO2002027010A1 (en)
AU (1) AU2001292303A1 (en)
WO (1) WO2002027010A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2621690A1 (en) * 1975-05-20 1976-12-09 Ciba Geigy Ag NEW ANTIBIOTIC AND METHOD OF ITS MANUFACTURING
JPH0822236B2 (en) * 1987-01-30 1996-03-06 三菱化学株式会社 Method for producing polycyclic xanthone compound
JPH02167092A (en) * 1988-12-19 1990-06-27 Kirin Brewery Co Ltd Anti-tumor agent containing lisolipin x and production of lisolipin x
JPH0426625A (en) * 1990-05-22 1992-01-29 Banyu Pharmaceut Co Ltd Antitumor agent containing lysolipins as active ingredient
IN172911B (en) * 1991-02-26 1994-01-01 Hoechst India

Also Published As

Publication number Publication date
JPWO2002027010A1 (en) 2004-02-05
WO2002027010A1 (en) 2002-04-04

Similar Documents

Publication Publication Date Title
AU2002218266A1 (en) Novel indanylidene compounds
AU2002225730A1 (en) Compounds
AU2000267458A1 (en) Hypercomputer
AU2001292518A1 (en) Novel compounds
AU2001239310A1 (en) Decahydro-isoquinolines
AU2001220246A1 (en) Neckphone
AU2001266345A1 (en) Five-membered-ring compound
AUPQ661800A0 (en) Insulin-potentiating compounds
AU2001239765A1 (en) Novel compounds
AU2001246998A1 (en) Novel compounds
AU2001281965A1 (en) Novel 6-phenylphenanthridines
AU2001253362A1 (en) Novel compounds
AU2001265871A1 (en) Substituted sulfonylaminopyrimidines
AU2001258255A1 (en) Substituted benzoylcyclohexenones
AU2002231077A1 (en) Novel compounds
AU2001254731A1 (en) Substituted phenyluracils
AU2001256964A1 (en) Novel compounds
AU2002225724A1 (en) Motilide compounds
AU2001234313A1 (en) Novel phenylheteroalkylamine derivatives
AU2002217285A1 (en) Compounds
AU2001230689A1 (en) Novel compounds
AU2002221923A1 (en) Novel compounds
AU2002216060A1 (en) Novel compounds
AU2001276890A1 (en) Novel compounds
AUPQ575300A0 (en) New compound